| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.35 | 6e-07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |